Experimental Alzheimer’s Drug Shows Promise

A new analysis of a study on an experimental Alzheimer’s drug reinforces the notion that the compound is broadly effective at improving the cognitive function of mild to moderate Alzheimer’s patients.A second analysis of the trial on the medication, known as Dimebon, also reveals that by improving the Alzheimer’s patients’ ability to perform daily tasks, the drug shaves off almost an hour a day in the amount of time the average caregiver must attend to his or her patient.The twin observations raise hope for a new and improved therapy to address both the symptoms and the underlying mechanisms driving a disease that the Alzheimer’s Association says currently affects more than 5 million Americans.

Read the full article on www.msn.com

Source: www.msn.com